Methyltransferase Setdb1 Promotes Osteoblast Proliferation by Epigenetically Silencing Macrod2 with the Assistance of Atf7ip

Cells. 2022 Aug 19;11(16):2580. doi: 10.3390/cells11162580.

Abstract

Bone loss caused by mechanical unloading is a threat to prolonged space flight and human health. Epigenetic modifications play a crucial role in varied biological processes, but the mechanism of histone modification on unloading-induced bone loss has rarely been studied. Here, we discovered for the first time that the methyltransferase Setdb1 was downregulated under the mechanical unloading both in vitro and in vivo so as to attenuate osteoblast proliferation. Furthermore, we found these interesting processes depended on the repression of Macrod2 expression triggered by Setdb1 catalyzing the formation of H3K9me3 in the promoter region. Mechanically, we revealed that Macrod2 was upregulated under mechanical unloading and suppressed osteoblast proliferation through the GSK-3β/β-catenin signaling pathway. Moreover, Atf7ip cooperatively contributed to osteoblast proliferation by changing the localization of Setdb1 under mechanical loading. In summary, this research elucidated the role of the Atf7ip/Setdb1/Macrod2 axis in osteoblast proliferation under mechanical unloading for the first time, which can be a potential protective strategy against unloading-induced bone loss.

Keywords: Setdb1; bone loss; cell proliferation; mechanical unloading.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Phenomena*
  • Cell Proliferation / genetics
  • DNA Repair Enzymes
  • Epigenesis, Genetic*
  • Glycogen Synthase Kinase 3 beta
  • Histone-Lysine N-Methyltransferase / genetics
  • Humans
  • Hydrolases
  • Osteoblasts
  • Repressor Proteins / metabolism

Substances

  • ATF7IP protein, human
  • MACROD2 protein, human
  • Repressor Proteins
  • Histone-Lysine N-Methyltransferase
  • SETDB1 protein, human
  • Glycogen Synthase Kinase 3 beta
  • Hydrolases
  • DNA Repair Enzymes

Grants and funding

This research was funded by the National Natural Science Foundation of China (Grant No. 31971171 to F.S., 31570939 to S.Z.), the Key Pre-research Project of Manned Spaceflight (Grant No. 020106 to S.Z.), Aerospace Medical Experiment Project of China Space Station (Grant No. HYZHXM01006 to S.Z.) and the Innovation Capability Support Program of Shaanxi, China (Grant No. 2020KJXX-060 to Z.H.).